UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2019-01, Vol.37 (3), p.190-201

2019

Volltextzugriff (PDF)

Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma

Cancer, 2016-02, Vol.122 (4), p.559-564

2016

Volltextzugriff (PDF)

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment

Blood, 2015-08, Vol.126 (7), p.863-872

2015

Volltextzugriff (PDF)

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma

Annals of oncology, 2015-08, Vol.26 (8), p.1667-1677

2015

Volltextzugriff (PDF)

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

The New England journal of medicine, 2002-06, Vol.346 (25), p.1937-1947

2002

Volltextzugriff (PDF)

High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL

Leukemia, 2023-02, Vol.37 (2), p.422-432

2023

Volltextzugriff (PDF)

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Blood, 2007-03, Vol.109 (5), p.1857-1861

2007

Volltextzugriff (PDF)

Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes

The New England journal of medicine, 2004-04, Vol.350 (18), p.1828-1837

2004

Volltextzugriff (PDF)

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5

Blood, 2007-01, Vol.109 (2), p.478-485

2007

Volltextzugriff (PDF)

Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

BMC cancer, 2024-01, Vol.24 (1), p.72-72, Article 72

2024

Volltextzugriff (PDF)

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Journal of clinical oncology, 2005-08, Vol.23 (22), p.5027-5033

2005

Volltextzugriff (PDF)

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Haematologica (Roma), 2010-08, Vol.95 (8), p.1342-1349

2010

Volltextzugriff (PDF)

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

Journal of clinical oncology, 2006-07, Vol.24 (19), p.3121-3127

2006

Volltextzugriff (PDF)

Role of Bruton's tyrosine kinase in B cells and malignancies

Molecular cancer, 2018-02, Vol.17 (1), p.57-57, Article 57

2018

Volltextzugriff (PDF)

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Blood, 2006-06, Vol.107 (11), p.4207-4213

2006

Volltextzugriff (PDF)

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Cochrane database of systematic reviews, 2007-10, Vol.2010 (4), p.CD003805

2007

Volltextzugriff (PDF)

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Blood, 2003-06, Vol.101 (11), p.4279-4284

2003

Volltextzugriff (PDF)

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience

Annals of oncology, 2006-01, Vol.17 (1), p.123-130

2006

Volltextzugriff (PDF)

Treatment for Primary CNS Lymphoma: The Next Step

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3144-3150

2000

Volltextzugriff (PDF)

Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era

Journal of clinical oncology, 2016-05, Vol.34 (13), p.1443-1447

2016

Volltextzugriff (PDF)

Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy

Leukemia & lymphoma, 2016-06, Vol.57 (6), p.1335-1341

2016

Volltextzugriff (PDF)

Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version

Annals of hematology, 2023-08, Vol.102 (8), p.2279-2282

2023

Volltextzugriff (PDF)

Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin

Journal of clinical oncology, 2005-04, Vol.23 (12), p.2797-2804

2005

Volltextzugriff (PDF)

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

The New England journal of medicine, 2002-01, Vol.346 (4), p.235-242

2002

Volltextzugriff (PDF)

1 – 25 von 4.759

Suche als RSS-Feed

Aktive Filter

ThemaAntineoplastic Combined Chemotherapy Protocols - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.174)
Mit Volltextzugriff
(3.507)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(4.728)
Science & Technology
(3.737)
Life Sciences & Biomedicine
(3.703)
Male
(3.102)
Female
(2.872)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(2.690)
Middle Aged
(2.505)
Aged
(2.177)
Oncology
(1.989)
Adult
(1.856)
Hematology
(1.694)
Treatment Outcome
(1.559)
Rituximab
(1.337)
Cyclophosphamide - Administration & Dosage
(1.319)
Vincristine - Administration & Dosage
(1.253)
Prognosis
(1.233)
Cyclophosphamide - Therapeutic Use
(1.171)
Vincristine - Therapeutic Use
(1.167)
Doxorubicin - Administration & Dosage
(1.148)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(4.759)
EZB*
(2.289)
Journals@Ovid Full Text
(2.071)
Ingenta.com
(1.523)
Publisher website
(979)
IngentaConnect Journals
(893)
Wiley-Blackwell Journals
(761)
Wiley Online Library Full Collection 2018
(671)
Elsevier ScienceDirect Journals Collection
(510)
Springer Journals
(505)
Taylor & Francis
(499)
Taylor & Francis Journals Collection
(491)
Taylor & Francis Journals Complete
(459)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(389)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(245)
Nature Journals
(182)
Nexis Uni
(157)
SpringerLink Series
(105)
BMJ Journals
(79)
Oxford Journals
(61)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(28)

Menü

Weitere Dienste

Einstellungen

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma

Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma

EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma

The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes

Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5

Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

Role of Bruton's tyrosine kinase in B cells and malignancies

Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative study

Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

Rituximab plus CHOP (R-CHOP) overcomes bcl-2—associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)

Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience

Treatment for Primary CNS Lymphoma: The Next Step

Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era

Clinical significance of co-expression of MYC and BCL2 protein in aggressive B-cell lymphomas treated with a second line immunochemotherapy

Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version

Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

Aktive Filter

Suchergebnisse filtern